Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>Recently passed legislation allows Texas clinics to bypass FDA approval for investigational stem cell treatments for patients with certain severe chronic diseases or terminal illnesses. The law alarmed ethicists who have been monitoring these practices.</p>

Unethical Marketing Practices for Stem Cell Treatments Continue

‘Significant and growing’ problem